Request Deal Involvement

GL Ventures and Temasek led a $230m Series C funding round in Clover Biopharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

LifeSci Partners

pr advisors

LifeSci Partners

or

Principals

OCEANPINE CAPITAL

bidder

OCEANPINE CAPITAL

GL VENTURES

bidder

GL VENTURES

TEMASEK HOLDINGS LIMITED

bidder

TEMASEK HOLDINGS LIMITED

HILLHOUSE CAPITAL GROUP

bidder

HILLHOUSE CAPITAL GROUP

CLOVER BIOPHARMACEUTICALS

target

CLOVER BIOPHARMACEUTICALS

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

DELOS CAPITAL

bidder

DELOS CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - GL Ventures and Temasek led a $230m Series C funding round in Clover Biopharmaceuticals.